Molecular therapeutic targets for bladder cancer.
Zacharakis
Evangelos
E
Monem
Mahmoud
M
Joseph
Jean V
JV
Patel
Hiten R H
HR
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D016503:Drug Delivery Systems; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D036341:Intercellular Signaling Peptides and Proteins; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology
D000970:Antineoplastic Agents; D036341:Intercellular Signaling Peptides and Proteins